ECRIN is proud to announce that it has now published its 2018 annual report.
ECRIN participated in the EURORDIS Summer School from 10 to 14 June 2019 in Barcelona, Spain.
ECRIN has now launched the 2019 call for its Data Centre Certification programme.
This programme identifies non-commercial clinical trials units (CTUs) in Europe that have demonstrated they can provide safe, secure, compliant and efficient management of clinical research data.
EU-OPENSCREEN-DRIVE is offering funding for chemoproteomics and small molecule screen projects.
5th Call for TRANSVAC2 Training Modules
M10 - Assay Development and Validation-Application of SPR Technologies in Vaccine development and manufacturing
Venue: Fraunhofer IME, Aachen Germany
Dates: 10-11 October 2019
FAIR PARK II (Conservative Iron Chelation as a Disease-Modifying Strategy in Parkinson's Disease), an ECRIN-supported clinical trial, has released its June 2019 newsletter.
The EULAC PerMed (Widening EU-CELAC policy and research cooperation in Personalised Medicine) project website is now online.
Health Research Board Clinical Research Coordination Ireland (HRB CRCI) hosted a conference to celebrate International Clinical Trials Day (ICTD) 2019.
The ECRAID-plan Consortium and Working Group meeting took place from May 20-21st in Amsterdam. The objectives of the consortium meeting were to:
Press Release: International Clinical Trials Day 2019: Patient stratification studies: challenges and opportunities
Press Release – Paris, May 2019.
In April 2019 TRANSVAC2 launched a fourth call for Training Modules (M6, M7 and M9) offered by the TRANSVAC2 project. The deadline has been extended to 1 June 2019. For more information, see below:
The PedCRIN funded WE Study (Walking Easier with cerebral palsy) is a double blind placebo controlled randomized trial in children between 4-17 years.
The Congress of join European Neonatal Societies (jENS 2019) represents a renowned interna
ECRIN 'CAMPUS' is back online!
ECRIN held a training session for auditors involved in its Data Management (DM) Centre Certification programme on 10 April 2019 in Paris.
The PedCRIN-funded trial POPART (Prophylactic Oropharyngeal Surfactant for Preterm infant: A Randomised Trial) has started recruiting
TRANSVAC: European Vaccine Research and Development Infrastructure - Open Call for Vaccine Development Services
The TRANSVAC2 project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease in particular.